Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SERPINE4P is designated as a **pseudogene** within the serpin superfamily. Serpins are large and broadly distributed families of protease inhibitors with roles in various biological processes, but pseudogenes like SERPINE4P are typically nonfunctional remnants of ancestral genes that have lost their protein-coding capacity through mutation or duplication[1][3][4]. Pseudogenes do not produce functional proteins and, as such, do not function as therapeutic targets, biomarkers, or have mechanisms of action relevant to disease or drug interaction. The structure, function, and biological relevance described for serpins in general[1][3][4] do not apply specifically to SERPINE4P. SERPINE4P should not be considered a valid molecular target, drug target, or receptor. It is distinguished from functional serpins by its classification as a pseudogene, meaning it does not encode a functional product, and thus should be flagged as "is_incorrect: true" for most applications involving therapeutic or mechanistic target lists.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Serpin family E member 4, pseudogene (SERPINE4P).